Every person alive is a mutated human. Each of us carries dozens of DNA changes that neither of our parents had, plus thousands more that accumulated in our cells since we were conceived. The average person is born with roughly 70 to 100 brand-new mutations in every cell, and that number only grows with age. Far from being rare or alarming, mutation is the baseline condition of being human, and it has shaped everything from our ability to digest milk to our vulnerability to cancer.
How Many Mutations You Were Born With
When a sperm and egg combine, the resulting embryo does not receive a perfect photocopy of each parent’s DNA. Errors slip in during DNA replication, and some of those errors are never corrected. Large-scale sequencing studies that compare children’s genomes to their parents’ have pinned down the rate with increasing precision. One widely cited figure puts the genome-wide mutation rate at about 1.28 × 10⁻⁸ per base pair per generation, which works out to roughly 70 to 80 new single-letter changes per child.
A more recent study using five different sequencing technologies on a large four-generation family found a broader range: roughly 98 to 206 new mutations per transmission, depending on how you count. That estimate includes not just single-letter swaps but also small insertions, deletions, and changes in repetitive stretches of DNA that older methods tended to miss. About 74 or 75 of those were classic single-letter variants, consistent with earlier estimates, while the rest involved other types of structural change.
These numbers mean that you are not genetically identical to either parent. You are a new genetic entity, carrying a small but real set of changes that have never existed before in any human. Most of those changes land in stretches of DNA that do not code for anything critical, so they have no noticeable effect. A small fraction, though, land in genes or regulatory regions where they can alter how your body develops or functions.
Why Fathers Contribute More Mutations Than Mothers
The mutation rate is not split evenly between parents. Sperm-producing cells divide continuously throughout a man’s life, while egg cells are mostly formed before a woman is born. Each additional round of cell division is another chance for a copying error. The result is that fathers contribute roughly three to four times as many new mutations as mothers do. That ratio of about 3.5 paternal-to-maternal mutations holds up across multiple studies.
This difference has a practical consequence: a father’s age at conception matters. The older the father, the more cell divisions his sperm precursors have gone through, and the more mutations his children tend to inherit. Research has linked advancing paternal age to a higher rate of certain spontaneous conditions, and the underlying mechanism involves mutations that arise rarely but then expand within the testes through a process resembling how tumors grow. Mutant sperm-producing cells that happen to divide faster gradually take up a larger share of the testis, so the odds of passing along those specific mutations increase with time.
Mutations That Keep Accumulating After Birth
The mutations you were born with are only the beginning. Every cell in your body continues to acquire new DNA changes throughout your life, a phenomenon called somatic mosaicism. By adulthood, different tissues in your body carry slightly different genomes, because each lineage of cells has picked up its own set of errors. This accumulation of post-birth mutations is a universal feature of human aging, observed across every tissue type that researchers have examined.
The rate and pattern vary by tissue. Cells that divide frequently, like those lining the gut or producing blood, accumulate mutations faster than cells that rarely divide, like muscle fibers. Over decades, some of these somatic mutations land in genes that control cell growth, which is one reason cancer risk climbs with age. But most somatic mutations are passengers: they ride along without doing anything harmful, quietly making your genome a patchwork of slightly different versions of itself.
There are also more exotic sources of internal mutation. Jumping genes, known as LINE-1 retrotransposons, are DNA sequences that can copy themselves and insert into new locations in the genome. Researchers have theorized that this process contributes to somatic mosaicism, particularly in the brain. However, single-neuron sequencing suggests the actual rate of new LINE-1 insertions in brain cells is quite low, with most neurons showing no detectable somatic insertions.
When Broken DNA Repair Makes Everything Worse
Your cells have elaborate machinery for catching and fixing DNA damage before it becomes a permanent mutation. When that machinery itself is broken, the consequences can be severe. Xeroderma pigmentosum is a genetic condition caused by mutations in genes responsible for a major DNA repair pathway. People with this condition face a skin cancer risk that can be several thousand-fold higher than the general population, because their cells cannot properly fix the DNA damage caused by ultraviolet light.
Studying the genomes of skin cancers from these patients has revealed how much repair normally protects us. In people with functioning repair, the mutation rate varies across the genome partly because repair is more active in some regions than others. In people without it, mutations pile up far more evenly, and the sheer volume of damage overwhelms whatever backup mechanisms exist. This gives researchers a window into how much of the mutation landscape in ordinary skin cancers is shaped by repair rather than by damage alone.
What the Sun Actually Does to Your DNA
Ultraviolet radiation is probably the most familiar environmental mutagen, and its signature in the genome is distinctive. UV light creates specific types of DNA damage, particularly at spots where two pyrimidine bases sit next to each other. When the cell tries to repair or replicate past this damage, it often makes a characteristic error: a C-to-T transition. This pattern is so consistent that researchers can look at the mutation profile of a tumor and identify UV exposure as the cause, often decades after the original sun damage occurred.
Studies of sun-exposed skin, even skin that has not developed cancer, find this UV signature stamped across the genome. The damage is not hypothetical or confined to extreme cases. Normal, non-cancerous skin from sun-exposed areas carries a measurable burden of UV-induced mutations. The mutations accumulate over a lifetime of exposure, which is why skin cancer risk is tied to cumulative sun exposure rather than to any single sunburn.
Radiation Exposure and the Chernobyl Surprise
If UV light reliably mutates skin cells, you might expect that ionizing radiation from nuclear accidents would leave a clear mark on the next generation. The evidence from Chernobyl, however, has been more reassuring than many people assume. A landmark study sequenced the complete genomes of 130 children born to parents who were exposed to fallout from the 1986 disaster. Despite some parents receiving substantial radiation doses, researchers found no increase in the rates or types of new mutations in their children compared to what earlier studies had established as normal.
An earlier, smaller study of Estonian cleanup workers had found a slight, statistically borderline increase in mutations at a specific type of repetitive DNA in children born after the accident to fathers who received the highest doses, but even that result was consistent with no effect at all. The whole-genome study, which had much more power to detect changes, found nothing. The takeaway is that while ionizing radiation clearly damages DNA in the cells it hits, the human germline appears to be surprisingly well-protected against passing those damages on to the next generation, at least at the exposure levels seen around Chernobyl.
Mutations That Became Superpowers
Pop culture tends to treat “mutated human” as shorthand for something dramatic and fictional. But real human mutations have produced traits that genuinely read like superpowers when you learn about them.
One of the most striking involves bone density. A family was identified carrying a single amino acid change in a gene called LRP5, swapping one building block for another at a specific position. Family members with this mutation had extraordinarily dense bones, with markers of bone formation dramatically elevated while bone breakdown remained normal. The mutation essentially jams a signaling pathway into overdrive, constantly stimulating new bone growth. Researchers have studied this mutation as a potential key to developing osteoporosis treatments.
Then there is the inability to feel pain. Mutations in the SCN9A gene, which encodes a sodium channel critical for pain signaling, can completely abolish pain perception. People born with two nonfunctional copies of this gene experience no pain at all, a condition that sounds appealing until you consider that pain is what stops you from leaving your hand on a hot stove. The same gene can also go wrong in the opposite direction: activating mutations cause excruciating episodes of spontaneous pain.
A mutation in the gene for apolipoprotein A-I, discovered in a small Italian town, provides another example. Carriers of this variant, called ApoA-I Milano, have very low levels of HDL cholesterol, the so-called “good” cholesterol. By conventional medical logic, that should put them at high risk for heart disease. Instead, carriers show no signs of premature cardiovascular disease, with normal artery thickness and a lower prevalence of atherosclerotic plaques compared to other people with similarly low HDL.
Mutations That Shaped Entire Populations
Some mutations did not just help individual families. They swept through entire populations because they offered a survival advantage in specific environments.
Lactase persistence is the classic example. Most mammals lose the ability to digest the milk sugar lactose after weaning, and most humans historically did too. But in populations that adopted cattle herding, mutations arose near the gene for lactase that keep it switched on into adulthood. In European populations, a single mutation explains the trait. In Africa and the Middle East, several different mutations independently achieved the same result, a striking case of evolution finding multiple solutions to the same problem.
High-altitude adaptation among Tibetans involves a different gene, EPAS1, which encodes a protein that regulates red blood cell production. Most people at very high altitude compensate by producing excessive red blood cells, which thickens the blood and creates health problems. Tibetans carry variants of EPAS1 that blunt this response, keeping hemoglobin levels lower and healthier. The frequency of these variants in Tibetans is dramatically higher than in lowland Han Chinese populations, a sign of strong natural selection. What makes this story even more remarkable is that the beneficial version of EPAS1 appears to have been inherited not from a human ancestor but from Denisovans, an archaic hominin group that interbred with the ancestors of modern Tibetans.
HIV resistance provides a more recent example. A 32-base-pair deletion in the CCR5 gene, called CCR5-Δ32, prevents the cell-surface protein from forming properly. Since HIV uses CCR5 as a doorway into immune cells, people who carry two copies of the deletion are nearly completely resistant to HIV infection, regardless of how much they are exposed. This discovery has driven an entire branch of antiviral research and inspired therapeutic strategies aimed at mimicking the deletion’s effect.
Archaic DNA Living Inside Modern Humans
One of the most unexpected findings of modern genomics is that most humans alive today carry DNA from species that went extinct tens of thousands of years ago. People outside Africa carry roughly one to four percent Neanderthal DNA, scattered across their genomes in small fragments. Some of those fragments have measurable effects on health and appearance today.
Studies linking Neanderthal DNA segments to medical records have found associations with neurological, psychiatric, immune, and skin-related traits. Neanderthal alleles contribute to variation in depression risk, the tendency to develop sun-related skin lesions, blood clotting behavior, and even tobacco use. In European-descent populations, specific Neanderthal alleles have been linked to red hair color and blood biomarker levels. In East Asian populations, Denisovan-introgressed DNA has been linked to coronary artery disease risk and immune-related blood markers.
This archaic DNA is not “junk” passively riding along. Some of it was actively favored by natural selection because it helped modern humans adapt to new climates, UV exposure levels, and pathogens as they spread across the globe. Other fragments were harmful and have been gradually weeded out over the millennia. The net result is that every person of non-African descent is a mosaic of modern and archaic human DNA, with real phenotypic consequences.
Mutations and Neurodevelopmental Conditions
New mutations do not only cause rare single-gene disorders. They also play a substantial role in common complex conditions. Autism spectrum disorder is one of the best-studied examples. De novo mutations, meaning ones that appeared fresh in the affected child and were not present in either parent, have emerged as a major source of genetic risk for autism. One large study estimated that de novo events contribute to roughly 30 to 39 percent of all autism cases, and an even higher share, 52 to 67 percent, in families with no prior history of the condition.
This finding reshapes how we think about genetic risk. For a family with one autistic child, the question of recurrence risk depends partly on whether the child’s condition was driven by a de novo mutation (which would be unlikely to recur) or by inherited variants (which could appear again in a sibling). Massive sequencing efforts involving tens of thousands of cases have identified specific genes where de novo mutations significantly raise autism risk, moving the field from general associations toward specific biological pathways.
Editing Mutations With CRISPR
If mutations cause disease, the logical next step is to fix them. Gene editing with CRISPR-Cas9 has moved from laboratory concept to clinical reality faster than most researchers expected. Sickle cell disease, caused by a single well-understood mutation in the hemoglobin gene, was an early target. In clinical studies, patients received their own blood stem cells after those cells had been edited to reactivate fetal hemoglobin, a form of hemoglobin that is normally silenced after infancy but that can compensate for the defective adult version.
Early results were dramatic. Patients who had previously needed regular blood transfusions became transfusion-independent, and those with sickle cell disease saw their painful vaso-occlusive crises disappear. Follow-up showed stable editing in bone marrow cells more than a year later, with fetal hemoglobin broadly distributed across red blood cells. In one study, fetal hemoglobin reached 19 to 27 percent of total hemoglobin, with 70 to 88 percent of red cells producing it. These outcomes led to regulatory approval of the first CRISPR-based therapies, marking a turning point in how medicine approaches genetic disease.
The irony is worth noting: the treatment works not by correcting the sickle cell mutation directly but by introducing a different intentional change that reactivates a backup gene. In a sense, the therapy fights one mutation by creating another.
Carrying Someone Else’s Mutations
There is one more way your body can harbor DNA that differs from your own genome, and it has nothing to do with errors in replication. Microchimerism is the presence of small populations of cells with a completely different genetic background within your body. It happens most commonly during pregnancy, when fetal cells cross the placenta and take up residence in the mother’s tissues, and maternal cells do the same in the fetus.
Autopsy studies of women who died during or shortly after pregnancy have found these foreign cells distributed across multiple organs. The lungs were the most chimeric, followed by the spleen, liver, kidney, brain, and heart, with chimeric cell counts significantly higher in pregnant women than in non-pregnant women. Some of these cells were identified as immune cells or blood stem cell precursors, suggesting they are not just passively lodged but potentially functional. Microchimerism can persist for decades after a pregnancy, meaning that many mothers carry a small population of cells with their child’s genome, and many adults carry cells with their mother’s genome, for most of their lives.
Whether these foreign cells help or harm is still debated. They have been studied in relation to autoimmune disease, cancer, tissue repair after injury, and transplant outcomes. But the basic fact of their existence adds another layer to what it means to be a “mutated human.” Your body does not contain a single uniform genome. It contains a shifting, aging, accumulating collection of genetic variants, some inherited, some spontaneous, some borrowed from another person entirely.
Myostatin and the Genetics of Muscle Growth
Myostatin is a protein that acts as a brake on muscle growth. When it works normally, it limits how large muscles can get. Loss-of-function mutations in the myostatin gene have been documented in several mammal species, always with the same basic result: substantially increased skeletal muscle mass. In cattle, these mutations produce the exaggerated musculature seen in certain beef breeds. In humans, rare cases of children born with myostatin mutations have shown unusual muscular development from infancy.
What makes myostatin especially interesting from an evolutionary perspective is that the human gene shows signs of positive natural selection. The pattern of DNA changes across human populations includes more protein-altering variants than you would expect by chance, suggesting that tweaks to muscle growth regulation were favored at some point in human history. This does not mean humans are evolving toward comic-book physiques, but it does mean that the genetic controls on muscle size have been under active evolutionary pressure, not just sitting idle since our species appeared.